ELF3 emerges as a novel prognostic indicator implicated in gastric cancer progression and correlated with unfavorable clinical outcomes

Figure 1 Pan-cancer and multi-cohort analysis verifies E74-like ETS transcription factor 3 upregulation in stomach adenocarcinoma. A: E74-like ETS transcription factor 3 (ELF3) mRNA level was upregulated in various types of malignancies from the TIMER database, including stomach adenocarcinoma (STAD); B: ELF3 mRNA level was markedly increased in STAD tissues from the UALCAN database; C: ELF3 protein expression level in STAD. Immunohistochemistry images of ELF3 in STAD and normal gastric tissues in the HPA database. ^aP < 0.05, ^bP < 0.01, and ^cP < 0.001. ELF3: E74-like ETS transcription factor 3; STAD: Stomach adenocarcinoma.